Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Arcus Biosciences Inc.
RCUS
$
32.28
-17%
Mon January 4th, 2021
13:34
Analysis
Are Options Traders Betting on a Big Move in Arcus Biosciences (RCUS) Stock?
Zacks
Mon November 23rd, 2020
12:48
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Arcus Biosciences started at outperform at Evercore ISI
MarketWatch
Tue July 28th, 2020
16:33
Earnings
Analysis
Arcus Biosciences, Inc. (RCUS) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
Zacks
Tue July 21st, 2020
17:31
IPO
Analysis
IPO Update: iTeos Therapeutics Finalizes IPO Plan
Seeking Alpha
Tue July 14th, 2020
12:18
Analysis
Arcus Biosciences, Inc.: An Oncology Stock With Newfound Prominence
Seeking Alpha
Thu July 2nd, 2020
19:59
IPO
Analysis
iTeos Therapeutics Begins U.S. IPO Rollout
Seeking Alpha
Mon June 29th, 2020
15:30
Analysis
Has Arcus Biosciences (RCUS) Outpaced Other Medical Stocks This Year?
Zacks
Tue June 23rd, 2020
18:12
Analysis
Arcus Biosciences (RCUS) Investor Presentation - Slideshow
Seeking Alpha
Fri June 12th, 2020
15:30
Analysis
Is Arcus Biosciences (RCUS) Stock Outpacing Its Medical Peers This Year?
Zacks
Wed June 10th, 2020
14:15
Analysis
Small Caps Build Steam And Biotechs Remain Well-Positioned
Seeking Alpha
Fri May 29th, 2020
18:50
Analysis
Here's Why Arcus Biosciences Stock Gained as Much as 15.9% Today
The Motley Fool
Thu May 28th, 2020
14:55
Analysis
Gilead Inks 10-Year Deal With Arcus for Immuno-oncology Drugs
Zacks
Wed May 27th, 2020
20:21
Analysis
Here's Why Arcus Biosciences Is Losing Ground Today
The Motley Fool
